Articles

Bladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission.

Ford Motor Credit and Toyota Motor Corp. were among roughly a dozen big companies embarking on roughly $26.5 billion corporate bond-borrowing spree on the first trading day of 2024.

Post Content

Oil traders are, for now, looking past rising tensions in the Red Sea. But there is "clear and present danger" of a wider conflict involving Iran, a top Wall Street commodities analyst warned in a note Tuesday.

The overnight U.S. financing rate, which soared to a record high of 5.4% last Thursday ahead of year-end, is likely to remain elevated over the next few weeks because of robust demand for funding, according to strategist Joseph Abate of Barclays.

Post Content

Bitcoin could reach an all-time high in 2024 and may end the year at around $80,000, according to analysts at AllianceBernstein.

U.S. stocks are likely to start 2024 with a breather and to remain data-dependent until the start of fourth-quarter earnings season, according to Oppenheimer Asset Management.

A new year often sparks optimism, but in Washington it's starting off with warnings that a partial government shutdown could hit in a couple of weeks.

Market participants are aggressively penciling in rate cuts for 2024. Here's what they'll be watching in the Fed minutes.

Massive returns across assets in the last two months of 2023 turned bond losses into gains,  according to Deutsche Bank Research.

One Wall Street equity strategist shared these five questions with clients in his first report of the new year.